Working… Menu

Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02135757
Recruitment Status : Completed
First Posted : May 12, 2014
Last Update Posted : March 30, 2018
Personalized Medicine Partnership for Cancer
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2018
Actual Study Completion Date : March 2018